Dengue Vaccines
Current Topics in Microbiology and Immunology · 2025
DOI: 10.1007/82_2025_320 ↗At a glance
Übersichtsarbeit in Current Topics in Microbiology and Immunology, 2025. Written by Silvia Beatriz Boscardin. Institution: Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil. sbboscardin@usp.br. Major MEDLINE topics: Dengue Vaccines, Dengue, Dengue Virus. Cited 2 times so far (Crossref); 151 references.
Abstract (original language)
This chapter offers an overview of dengue vaccines that have advanced to clinical trials, addressing the intricate challenges in their development. It details the complexities of the dengue virus, including its four serotypes and the phenomenon of antibody-dependent enhancement (ADE), which significantly impacts vaccine design. The chapter reviews the historical trajectory and current landscape of vaccine candidates, such as Dengvaxia®, Qdenga®, and Butantan-DV, analyzing their efficacy, safety profiles, and the lessons learned from their clinical trials. It also discusses other hurdles like suitable animal models and viral interference. Ultimately, the chapter highlights the advancements made and outlines future research directions crucial for a universally effective dengue vaccine.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil. sbboscardin@usp.br.
Cite
APA
Boscardin, S. B. (2025). Dengue Vaccines. Current Topics in Microbiology and Immunology. https://doi.org/10.1007/82_2025_320
Vancouver
Boscardin SB. Dengue Vaccines. Current Topics in Microbiology and Immunology. 2025. doi:10.1007/82_2025_320
BibTeX
@article{Boscardin2025,
author = {Boscardin, Silvia Beatriz},
title = {Dengue Vaccines},
journal = {Current Topics in Microbiology and Immunology},
year = {2025},
doi = {10.1007/82_2025_320}
}
EUVIMED